TARRYTOWN, N.Y.--(BUSINESS WIRE)--Regulatory News: EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm Exchange: EPCT) (the “Company”) announced today that a previously authorized 1-for-3 reverse stock split of its common stock has been consummated and will be in effect as follows:
